T
TBET
vs
S&P 500
S&P 500
Over the past 12 months, TBET has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +33% growth.
Stocks Performance
TBET vs S&P 500
Performance Gap
TBET vs S&P 500
Performance By Year
TBET vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Tibet Pharmaceuticals Inc
Glance View
Tibet Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the research, development, manufacturing and marketing of modernized traditional Tibetan medicines. The company employs 190 full-time employees The company went IPO on 2011-01-25. The firm sells both prescription and over-the-counter traditional Tibetan medicines. As of December 31, 2009, it had developed five pharmaceutical products. The firm sells its products principally to distributors in People's Republic of China, who in turn sell them to hospitals, hospital pharmacies and retail pharmacies. The Company’s products include 25 Ingredients Mandrake Pill, 28 Ingredients Pinang Pill, 18 Ingredients Chebulic (Myrobalan) Frusemide Pill, 15 Ingredients Gentiana Pill and Pomegranate Nichirin Pill.
